Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lactate reprograms PGE2 metabolism via GPR81 inhibits COX2 to relieved psoriasis.

Scientific reports·2026
Same author

Targeting chitinase-3-like protein 2 (CHI3L2) suppresses cell proliferation and migration in glioblastoma.

Translational cancer research·2026
Same author

VSIG2 as a novel immunosuppressive ligand interacts with Nectin-2 to regulate T cell responses.

Journal of neuroinflammation·2025
Same author

An antibody targeting an immune checkpoint molecule BTN2A2 enhances anti-tumor immunity.

Neoplasia (New York, N.Y.)·2025
Same author

A review for the impacts of circadian disturbance on urological cancers.

Sleep and biological rhythms·2024
Same author

Microfluidic-based preparation of artificial antigen-presenting gel droplets for integrated and minimalistic adoptive cell therapy strategies.

Biofabrication·2024
Same journal

Correction: Kang et al. Fluid Flow to Electricity: Capturing Flow-Induced Vibrations with Micro-Electromechanical-System-Based Piezoelectric Energy Harvester. <i>Micromachines</i> 2024, <i>15</i>, 581.

Micromachines·2026
Same journal

Femtosecond Laser Texturing of Wood Coatings with Bio-Based Epoxy and Wax Additives for Enhanced Hydrophobicity.

Micromachines·2026
Same journal

Engineering of Optoelectronic Devices for Renewable Energy Applications.

Micromachines·2026
Same journal

Phase Transformation and Electrochemical Behavior of Hexagonal TiO<sub>2</sub> Nanotubes Under Different Annealing Temperatures and Heating Rates.

Micromachines·2026
Same journal

Process Optimization and Predictive Modeling of Femtosecond Laser Precision Milling for Commercial PMMA Slices.

Micromachines·2026
Same journal

A Hybrid Preprocessing Multi-Objective Surrogate Model for Thermal MEMS Actuators.

Micromachines·2026
See all related articles

Related Experiment Video

Updated: Jul 24, 2025

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K

Microfluidic Chips: Emerging Technologies for Adoptive Cell Immunotherapy.

Yishen Tian1, Rong Hu1, Guangshi Du1

  • 1Translational Medicine Research Center, Guizhou Medical University, Guiyang 550025, China.

Micromachines
|July 8, 2023
PubMed
Summary
This summary is machine-generated.

Microfluidic chips streamline adoptive cell therapy (ACT) preparation by enabling efficient cell isolation, screening, and culture. This technology offers a faster, cost-effective, and personalized approach to ACT for various cancers.

Keywords:
adoptive cell therapycell expandingcell sortingimmunotherapymicrofluidic chip

More Related Videos

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.3K
A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells
15:41

A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells

Published on: October 15, 2013

15.0K

Related Experiment Videos

Last Updated: Jul 24, 2025

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K
Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.3K
A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells
15:41

A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells

Published on: October 15, 2013

15.0K

Area of Science:

  • Biotechnology and Biomedical Engineering
  • Cellular and Molecular Medicine
  • Cancer Therapy

Background:

  • Adoptive cell therapy (ACT) shows promise for hematologic malignancies and solid tumors.
  • Current ACT preparation is complex, time-consuming, costly, and faces challenges in cell preparation.
  • Microfluidic technology offers precise fluid manipulation at micro/nano scales.

Purpose of the Study:

  • To review the advantages and applications of microfluidic chips in adoptive cell therapy.
  • To compare microfluidic methods with existing techniques for cell sorting, screening, and culture in ACT.
  • To discuss the challenges and future potential of microfluidics in ACT.

Main Methods:

  • Review of existing literature on microfluidic applications in cell sorting, screening, and culture.
  • Analysis of microfluidic chip advantages: high throughput, low cell damage, fast amplification.
  • Comparison of microfluidics with conventional methods for ACT preparation.

Main Results:

  • Microfluidic chips can significantly simplify ACT preparation steps, reducing time and cost.
  • The technology facilitates high-throughput cell isolation, screening, and incubation with minimal cell damage.
  • Customizable microfluidic chips align with the personalized nature of ACT.

Conclusions:

  • Microfluidics presents a powerful platform for advancing adoptive cell therapy.
  • The technology addresses key challenges in ACT preparation, enhancing efficiency and personalization.
  • Further research and development hold significant potential for microfluidics in clinical ACT applications.